THEME CRS INDIAN CHAPTER The Indian Pharmaceutical Industry currently tops the charts among India’s science based industry with new drug launches, new drug filings and phase II clinical trials in progress throughout the year. The pharmaceutical market continues to rise by virtue of the increasing sale of generics, diagnostic and FOURTEENTH INTERNATIONAL SYMPOSIUM OF clinical trial services. Competent workforce, cost-effective CONTROLLED RELEASE SOCIETY - INDIAN CHAPTER chemical synthesis, strong legal and financial frame-work, and ON ADVANCES IN TECHNOLOGY AND BUSINESS POTENTIAL OF NEW DRUG DELIVERY SYSTEMS globalization make the Indian Pharmaceutical Industry a frontrunner in a wide range of specialities. Developing platform technologies promises to be an area of exciting technological innovation which gives a new life to the molecule with patent protection and good market share and also offers improved safety, efficacy and patient compliance. Monday 23rd and Tuesday 24th While the development of NCEs demand huge investment of February, 2015 time and funds, it costs significantly less to develop new methods of administration of an existing drug. Hence, pharmaceutical companies have to strive hard under constant Organised By: CONTROLLED RELEASE SOCEITY INDIAN CHAPTER stress to maximize the full prospective of a drug candidate at an early stage of its life cycle. Drug resistance, latency of infection, newer infectious diseases, sudden epidemics along with increased incidence of cancer and life style diseases have set Supported By INSTITUTE OF CHEMICAL TECHNOLOGY MUMBAI the pace for accelerated research in drug delivery strategies to come up with newer more effective, practical and cost effective solutions. The focus of the 14th CRS-IC symposium is to provide a common platform to industry personnel, academicians, research scientists and Venue students to discuss various aspects of development and K. V. AUDITORIUM management of novel delivery systems including regulatory issues INSTITUTE OF CHEMICAL TECHNOLOGY and business aspects. Topics like Quality by design and PAT MATUNGA (EAST), MUMBAI- 400 019 would also be deliberated. Poster sessions while showcasing research in various aspects of drug delivery, would provide a forum for interaction between faculty, delegates and students. Controlled Release Society (CRS Inc) with over 4000 members worldwide is global scientific society. It is an international organization for the promotion and development of novel drug delivery systems, with the headquarters in Minneapolis, Minnesota, USA and liaison offices in Geneva, Switzerland and Kawasaki, Japan. The Indian Local Chapter of Controlled Release Society (CRSIC) was established in 1994 with headquarters at PERD Centre, Ahmedabad and regional office at SciTech Centre, Jogeshwari, Mumbai. It is nd recognized as the 2 most active chapter amongst the nineteen local nd chapters of CRS Inc. At the 32 Annual Meeting of CRS Inc. in Vienna, Austria the CRSIC was awarded a special certificate of recognition for outstanding service to CRS Inc. The mission of CRSIC is to promote education, create awareness and to encourage scientific research towards the creation of intellectual wealth in the area of drug delivery systems in India. CRSIC regularly organizes workshops and international symposia with a focus on advances in technology and business potential of novel drug delivery systems. SYMPOSIUM HIGHLIGHTS Scientific Session: Speakers would present recent developments in drug delivery systems, highlight materials science and engineering, the cellular and biological response to materials, the response of various formulations to materials, and the translational considerations, with a common focus on the controlled delivery of active agents. Poster Session: Young Scientists will have an opportunity to present a concise overview of their research study. The posters will provide a platform for discussion a forum to exchange ideas and ample opportunity for networking. Oral Presentations: Posters with high scientific caliber will be selected for oral presentations. Technology Showcase: The "Technology Showcase" would highlight recent developments in excipients drug delivery technologies, process and analytical equipments while providing opportunity to companies to showcase their products to professionals specializing in drug delivery, delegates would have benefit of being updated with the state of art information. SCIENTIFIC COMMITTEE EXECUTIVE COMMITTEE PATRONS Vandana Patravale Chairperson H. L. Bhalla President Emeritus Pankaj Patel Dilip Sanghvi Amrita Bajaj Member Amarjit Singh President Ajit Singh Kirti Patel Roop Khar Member Anisha Pargal Vice-President Himadri Sen Amarjit Singh R. Manavlan Member Vandana Patravale Vice-President Kamlesh Oza F. V. Manvi Mangal Nagarsenkar Member Ganga Srinivasan Secretary Anisha Pargal Amrita Bajaj Sanjay Jain Member Hitesh Doshi Treasurer H. L. Bhalla Harish Padh Om Prakash Katare Member Sujata Sawarkar Member Padma Devarajan Kamalinder Singh Varsha Pokharkar Member Munira Momin Member Vandana Patravale Harish Shah Sanyog Jain Member N. Udupa Member Munira Momin Member John Disouza Member Manju Mishra Member Kamalinder Singh Member Manish Nivsarkar Member Sujata Sawarkar Member Maharukh Rustomjee Member Sarabjit Singh Member Shripad Jathar Member REGISTRATION FORM REGISTRATION DATES AND FEES FOURTEENTH INTERNATIONAL SYMPOSIUM OF CONTROLLED RELEASE SOCIETY - INDIAN CHAPTER ON ADVANCES IN TECHNOLOGY AND BUSINESS POTENTIAL OF Category Before Feb. 10th 2015 After Feb. 10th 2015 Students Rs. 2500 /- Rs. 3000 /- Academicians Rs. 4000 /- Rs. 5000 /- Industry Rs. 7000 /- Rs. 8000 /- Foreign Delegates: Students 300 USD 350 USD Foreign Delegates: Academicians 500 USD 550 USD NEW DRUG DELIVERY SYSTEMS 23rd and 24 th Note: Spot Registration subject to availability February 2015 Registration fee is inclusive of Service Tax (TO BE FILLED IN BLOCK LETTERS) Payment Mode Demand draft/ Cheque to be made payable at Mumbai in favor of: Controlled Release Society - Indian Chapter Salutation: Mr. /Mrs. /Ms. /Dr. /Prof. Name:______________________________________________________ First Name Middle Name Last Name Mail the Registration Form and Fee to: Prof. Vandana B. Patravale A-261, Department of Pharmaceutical Sciences and Technology Institute of Chemical Technology Mumbai-400 014 Email ID: abstracts.crsic@gmail.com Date of Birth: _________ (Date)/ ______________ (Month)/ _______ (Year) Qualification: ____________________________________________ Designation: _________________________________________________ Department/ Division: _______________________________ REGISTRATION INFORMATION Company/ Institute: ___________________________________________ Address: ______________________________________________________ • ______________________________________________________________ City: ______________________State: ______________________________ • Pin/ Zip Code: __________________ Country: _____________________ • Telephone: ________________________ Fax: ____________________ • E mail ID: ______________________________________________ Payment Details • • Please fill the attached Registration Form and post it along with the Bank Draft/Cheque with your name written at the back of draft/cheque. Kindly mention ‘CRS Registration’ in bold letter on the envelope carrying the registration form. Register at the earliest to avoid last minute disappointment due to space constraints. Students are requested to enclose a letter from the head of institution certifying their student status. Photocopies of the Registration Form may be used. No refund of Registration Fee in case of cancellation. D. D./ Cheque No.: _________________ Date: ______________________ Amount: ___________ Drawn on Bank : ___________________________ VENUE OF THE SEMINAR K.. V. AUDITORIUM INSTITUTE OF CHEMICAL TECHNOLOGY NATHALAL PAREKH MARG MATUNGA-400 019 MUMBAI, INDIA ACCOMODATION Delegates are requested to make their own arrangements for transport and accomodation. ABSTRACT SUBMISSION INSTRUCTIONS Submission Instructions 1. Mode of submission: Electronic by e-mail as 'MS word 2007 file attachment to be sent to abstracts.crsic@gmail.com 2. File Format: Submit 'MS word' file with tables, photos and graphs embedded within the text of document. (ALL IN BLACK AND WHITE ONLY) Margin: Top and bottom (1"), left and right (0.75") Abstract Title: Top of paper, centered; Font: All Capital, Bold, Times New Roman, 12 points Author Name(s): Last name followed by initials, presenting author to be underlined, Font: Times New Roman, 10 points, line spacing 1 with 0 point before and after paragraph Affiliation(s): Institution address, Font: Times New Roman, 10 points, line spacing 1 with 0 point before and after paragraph Email of the presenting author is compulsory, Font: Times New Roman, 10 points Key Words: Not more than 5 words, Times New Roman, 10 points Body Text: IN TWO COLUMNS with equal column width (3.13") and column spacing (0.5"), Font: Times New Roman, 10 points, line spacing 1 with 0 point before and after paragraph Subheadings: Font: All Capital, Bold, Times New Roman, 10 points 3. Abstract Contents: Title of paper, Authors names, Affiliations, Email address, Keywords, Introduction, Objective, Experimental methods, Results and Discussion , Conclusion , Ref erence s and Acknowledgments. Use of Graphs, Tables and Drawings is strongly recommended 4. Abstract length: Not more than one full page on standard A4 sized paper inclusive of all tables, photos and graphs. Visit www.crsic.org for sample abstract under ‘Quick Links’ th The last date for submission of abstracts is January 20 2015 NOTE : 1. Submitted abstracts should comply with the above specifications to be considered 2. List of accepted presentations will be displayed on the website, latest by th January 30 , 2015. 3. Only one paper per presenting author will be accepted. 4. Innovative papers will be selected for awards. Preliminary selection for awards would be based on the abstracts. In case you do not receive an acknowledgement for your abstract submission within 48 hours, you may drop a mail stating the same at: abstracts.crsic@gmail.com
© Copyright 2024